Export

Swedish Orphan Biovitrum AB (publ)

Financial information

The information source is the annual report of the company with business id 556038-9321

* Closing information (×1000) SEK

Fiscal year 202412 202312 (consolidated)
Number of months: 12 12
Turnover: 26,027,000 Revenue Up 22,123,000 Revenue Up
Financial expenses: 1,305,000 Revenue Up 1,162,000 Revenue Up
Earnings before taxes: 4,407,000 Revenue Up 2,954,000 Revenue Down
Total assets: 75,444,000 Revenue Up 74,027,000 Revenue Up
Current assets: 13,162,000 Revenue Up 12,671,000 Revenue Up
Current liabilities: 12,069,000 Revenue Down 19,095,000 Revenue Up
Equity capital: 40,286,000 Revenue Up 33,867,000 Revenue Up
Share capital: 195,000 Revenue Up 194,000 Revenue Up
Number of employees: 1,840 Revenue Up 1,772 Revenue Up

Financial ratios

Solvency: 53.4% Revenue Up 45.7% Revenue Down
Turnover per employee: 14,145 Revenue Up 12,485 Revenue Up
Profitability: 16.9% Revenue Up 13.4% Revenue Down
Return on equity (ROE): 10.9% Revenue Up 8.7% Revenue Down
Current ratio: 109.1% Revenue Up 66.4% Revenue Down
Return on assets (ROA): 7.6% Revenue Up 5.6% Revenue Down

Companies with similar products and services, and with detailed information

Fiscal year 202412
Number of months: 12
Turnover: 26,027,000
Financial expenses: 1,305,000
Earnings before taxes: 4,407,000
Total assets: 75,444,000
Current assets: 13,162,000
Current liabilities: 12,069,000
Equity capital: 40,286,000
Share capital: 195,000
Number of employees: 1,840

Financial ratios

Solvency: 53.4%
Turnover per employee: 14,145
Profitability: 16.9%
Return on equity (ROE): 10.9%
Current ratio: 109.1%
Return on assets (ROA): 7.6%